患者参加型癌化学療法副作用モニタリング―患者の治療参加と情報の共有化―

DOI Web Site Web Site 被引用文献6件 参考文献39件

書誌事項

タイトル別名
  • Monitoring the Side Effects of Cancer Chemotherapy with Patients-The Participation of Patients in Cancer Therapy and Sharing Patient Information-
  • カンジャ サンカガタガン カガク リョウホウ フクサヨウ モニタリング カンジャ ノ チリョウ サンカ ト ジョウホウ ノ キョウユウカ

この論文をさがす

抄録

  The purpose of this study was to assess patient participation in cancer therapy and the sharing of patient information among the medical care team (physicians, nurses, pharmacists, and especially patients). We monitored the side effects of cancer chemotherapy with patients, and developed two support tools: One scored the points of subjective symptoms (fatigue, anorexia, nausea, etc) by patients, and the other recorded objective symptoms (clinical examination data) by pharmacists. It is most important that they attend each patient at their bedside. At this time, the trial was evaluated by questionnaire survey by inpatients receiving cancer chemotherapy (n=15). As a result, all patients (15/15) responded that this trial was necessary. This trial addressed the following: 1) increased communication between patients and medical staff concerning side effects (14/15), 2) increased interest in side effects (10/15), 3) when a patient tells medical staff about side effects, they act on it (10/15). None of the patients felt inconvenienced by scoring every day (0/15), or anxiety about side effects (0/15). Furthermore, all patients (15/15) responded that “participation of pharmacists in cancer chemotherapy” was necessary. This trial revealed no problems and suggested that patients related to the center of medical care. We should be careful in interpreting results of this small sized trial; however, the following conclusions should be reached: 1) introduction of monitoring side effects of cancer chemotherapy with patients, 2) develop communication among the medical care team.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 126 (8), 629-642, 2006

    公益社団法人 日本薬学会

被引用文献 (6)*注記

もっと見る

参考文献 (39)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ